Related Experiment Videos

[Diode laser photocoagulation for retinopathy of prematurity--outcomes in one-year observation]

Joanna Kobylarz1, Anna Piwowarczyk, Bozena Romanowska-Dixon

  • 1Katedry i Kliniki Okulistyki Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie.

Klinika Oczna
|August 4, 2006
PubMed

Insights

Diode laser photocoagulation effectively treats retinopathy of prematurity (ROP), leading to good structural and functional outcomes in infants. This treatment ensures positive long-term visual health for affected children.

Area of Science:

  • Ophthalmology
  • Pediatric Medicine
  • Medical Technology

Context:

  • Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
  • Early and effective intervention is crucial to prevent severe visual consequences.
  • Transpupillary diode laser photocoagulation is a recognized treatment modality for ROP.

Purpose:

  • To assess the structural and functional results of transpupillary diode laser photocoagulation in one-year-old patients treated for ROP.
  • To evaluate visual acuity and ocular structural integrity post-treatment.
  • To analyze refractive outcomes, including myopia and hyperopia, following ROP treatment.

Summary:

  • A study examined 116 eyes of 58 infants at 12 months of age who received diode laser photocoagulation for ROP.
  • Functional outcomes (visual acuity) were good in 81.9% of eyes, and structural outcomes were good in 96.5%.
  • Refractive errors included hyperopia (64.6%) and myopia (31%).

Impact:

  • Diode laser photocoagulation demonstrates high efficacy in treating retinopathy of prematurity.
  • The findings support the use of this laser treatment for preserving visual function and ocular structure in infants.
  • Understanding refractive outcomes aids in long-term management and monitoring of treated children.
Abstract